Buying Welcome to Assets Maker, Gujarat’s Largest and most comprehensive property listing c...
Read more

Selling Welcome to Assets Maker, Gujarat’s Largest and most comprehensive property listing ...
Read more

Renting Welcome to Assets Maker, Gujarat’s Largest and most comprehensive property listing ...
Read more

Property News

August 29, 2014
  IIMB  Buyer survey
September 09, 2014
Ahmedabad The traditional m
September 09, 2014
Ahmedabad Housing projects
September 14, 2014
 global Wrold Trade Cente
September 16, 2014
 Dear All,   &
October 04, 2014
  Ahmedabad In the pres
October 04, 2014
  As Prime Minister Nare
October 04, 2014
  After a decade, the Ah
October 04, 2014
Prime Minister Narendra
October 05, 2014
The global Pharma industry i
Ahmedabad city good for pharma companies Future
October 05, 2014

The global Pharma industry is under serious pressure from a large number of innovator molecules facing patent expiration,
a thin pipeline of new drugs, regulatory challenges and pricing pressures. This has led to a directional shift towards the
emerging markets of Asia, Australia, Africa and Latin America, which are growing three times faster than the current
growth rates experienced in the industry’s leading markets of North America, Japan and Europe. We expect over 40% of
the global Pharma industry’s incremental growth over the next decade to come from the emerging markets.
The Indian Pharma industry is on the threshold of becoming a major global market by 2020. Many experts believe that
the Industry has the potential to grow at an accelerated 15 to 20% CAGR for the next 10 years to reach between US$49
billion to US$74 billion in 2020.
The Indian pharmaceuticals market is witnessing dynamic changing trends such as large acquisitions by multinational
companies in India, increasing investment by domestic and international players in India, deeper penetration into the rural
markets, growth and availability of healthcare and incentives for setting up special economic zones (SEZ’s). We believe
these trends combined with increased purchasing power and access to good quality medical care will continue to propel
the domestic pharmaceutical industry to new heights.
Indian Pharma companies are already major outsourcing partners of global Pharma companies. Research & Development
in India is getting more innovative. Domestic companies have strengthened their position in the world for supplying
solutions across the pharmaceutical value chain. They are likely to become a competitor of global Pharma in the areas
of manufacturing and R&D, and a potential partner in others.
In this report, we look at developments in the branded generics market, over-the-counter products (OTC), vaccines and
rural markets, and analyse what lies ahead for the industry as it aims to capitalise on the promise of the domestic market
place. We believe that the domestic Indian pharmaceutical market has a positive growth trajectory but will also face major
transformational challenges in the next decade. We address some of these challenges and identify key imperatives to
accelerate the domestic market’s growth.